Gap junctions and chagas disease.

Gap junction channels provide intercellular communication between cells. In the heart, these channels coordinate impulse propagation along the conduction system and through the contractile musculature, thereby providing synchronous and optimal cardiac output. As in other arrhythmogenic cardiac diseases, chagasic cardiomyopathy is associated with decreased expression of the gap junction protein connexin43 (Cx43) and its gene. Our studies of cardiac myocytes infected with Trypanosoma cruzi have revealed that synchronous contraction is greatly impaired and gap junction immunoreactivity is lost in infected cells. Such changes are not seen for molecules forming tight junctions, another component of the intercalated disc in cardiac myocytes. Transcriptomic studies of hearts from mouse models of Chagas disease and from acutely infected cardiac myocytes in vitro indicate profound remodelling of gene expression patterns involving heart rhythm determinant genes, suggesting underlying mechanisms of the functional pathology. One curious feature of the altered expression of Cx43 and its gene expression is that it is limited in both extent and location, suggesting that the more global deterioration in cardiac function may result in part from spread of damage signals from more seriously compromised cells to healthier ones.

[1]  J. Yarnold,et al.  Pathogenetic mechanisms in radiation fibrosis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  David D Spragg,et al.  Mechanisms Underlying Conduction Slowing and Arrhythmogenesis in Nonischemic Dilated Cardiomyopathy , 2004, Circulation research.

[3]  E. Hertzberg,et al.  Kainic acid induced alterations in antibody recognition of connexin43 and loss of astrocytic gap junctions in rat brain , 1994, Glia.

[4]  E. Hertzberg,et al.  Gap junction disappearance in astrocytes and leptomeningeal cells as a consequence of protozoan infection , 1998, Brain Research.

[5]  G. Haddad,et al.  Heart rhythm genomic fabric in hypoxia. , 2010, Biochemical and biophysical research communications.

[6]  D. Spray,et al.  Transcriptomic signatures of alterations in a myoblast cell line infected with four distinct strains of Trypanosoma cruzi. , 2010, The American journal of tropical medicine and hygiene.

[7]  Eric Oldfield,et al.  Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole. , 2006, Journal of medicinal chemistry.

[8]  M. Chanson,et al.  Gap junctional communication in tissue inflammation and repair. , 2005, Biochimica et biophysica acta.

[9]  B. Giepmans,et al.  The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein , 1998, Current Biology.

[10]  D. Spray,et al.  Pathology of mechanical and gap junctional co-coupling at the intercalated disc: Is sepsis a junctionopathy? , 2007, Critical care medicine.

[11]  D. Spray,et al.  Structural Changes in the Carboxyl Terminus of the Gap Junction Protein Connexin43 Indicates Signaling between Binding Domains for c-Src and Zonula Occludens-1* , 2004, Journal of Biological Chemistry.

[12]  M. Rioult,et al.  A trypanosome-soluble factor induces IP3 formation, intracellular Ca2+ mobilization and microfilament rearrangement in host cells , 1995, The Journal of cell biology.

[13]  D. Spray,et al.  Sex-dependent gene regulatory networks of the heart rhythm , 2010, Functional & Integrative Genomics.

[14]  B. Maciel,et al.  Pathogenesis of Chronic Chagas Heart Disease , 2007, Circulation.

[15]  D. Spray,et al.  Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection. , 2008, Genomics.

[16]  E. Hertzberg,et al.  Gap junction distribution is altered between cardiac myocytes infected with Trypanosoma cruzi. , 1992, Circulation research.

[17]  C. Fry,et al.  Alterations in cardiac connexin expression in cardiomyopathies. , 2006, Advances in cardiology.

[18]  J. Urbina,et al.  Amiodarone Inhibits Trypanosoma cruzi Infection and Promotes Cardiac Cell Recovery with Gap Junction and Cytoskeleton Reassembly In Vitro , 2010, Antimicrobial Agents and Chemotherapy.

[19]  D. Spray,et al.  CHAPTER 8 – Gap Junction Channels and Healing-Over of Injury , 2001 .

[20]  K. Willecke,et al.  Gap junctions and the connexin protein family. , 2004, Cardiovascular research.

[21]  G. Ávila,et al.  Role of TGF-β on cardiac structural and electrical remodeling , 2008, Vascular health and risk management.

[22]  W. Courchesne Characterization of a novel, broad-based fungicidal activity for the antiarrhythmic drug amiodarone. , 2002, The Journal of pharmacology and experimental therapeutics.

[23]  N. Andrews,et al.  Lysosomal Fusion Is Essential for the Retention of Trypanosoma cruzi Inside Host Cells , 2004, The Journal of experimental medicine.

[24]  D. Spray,et al.  Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy , 2003, Parasitology Research.

[25]  M. Kéramidas,et al.  Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy. , 2008, Cytokine & growth factor reviews.

[26]  G. Burnstock,et al.  Gap junction reduction in cardiomyocytes following transforming growth factor-beta treatment and Trypanosoma cruzi infection. , 2009, Memorias do Instituto Oswaldo Cruz.

[27]  M. Rossi,et al.  Reduction of gap and adherens junction proteins and intercalated disc structural remodeling in the hearts of mice submitted to severe cecal ligation and puncture sepsis* , 2007, Critical care medicine.

[28]  M. Toldo,et al.  Trypanosoma cruzi: do different sylvatic strains trigger distinct immune responses? , 2010, Experimental parasitology.

[29]  N. Sperelakis Heart physiology and pathophysiology , 2001 .

[30]  H. Katus,et al.  Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation , 2011, Drug design, development and therapy.

[31]  D. Paul,et al.  Connexins, connexons, and intercellular communication. , 1996, Annual review of biochemistry.

[32]  A. P. Riera,et al.  Chagas disease: state-of-the-art of diagnosis and management. , 2008, Cardiology journal.

[33]  P. Dorian,et al.  Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia , 2010, Vascular health and risk management.

[34]  N. Rodríguez,et al.  Amiodarone Destabilizes Intracellular Ca2+ Homeostasis and Biosynthesis of Sterols in Leishmania mexicana , 2009, Antimicrobial Agents and Chemotherapy.

[35]  N. Severs,et al.  Gap junction remodeling and cardiac arrhythmogenesis: cause or coincidence? , 2001, Journal of cellular and molecular medicine.

[36]  D. Spray,et al.  Transcriptomic alterations in Trypanosoma cruzi-infected cardiac myocytes. , 2009, Microbes and infection.

[37]  M. O. Masuda,et al.  Characterization of [Ca2+]i responses in primary cultures of mouse cardiomyocytes induced by Trypanosoma cruzi trypomastigotes. , 2003, Memorias do Instituto Oswaldo Cruz.

[38]  K. Otsu,et al.  Direct Association of the Gap Junction Protein Connexin-43 with ZO-1 in Cardiac Myocytes* , 1998, The Journal of Biological Chemistry.

[39]  Sha Liao,et al.  Amiodarone induces stress responses and calcium flux mediated by the cell wall in Saccharomyces cerevisiae. , 2009, Canadian journal of microbiology.

[40]  J. Hervé,et al.  Diversity in protein-protein interactions of connexins: emerging roles. , 2004, Biochimica et biophysica acta.

[41]  R. Hauer,et al.  The role of connexin40 in atrial fibrillation. , 2009, Cardiovascular research.

[42]  D. Spray,et al.  Cardiac connexins: genes to nexus. , 2006, Advances in cardiology.

[43]  Stefan Dhein,et al.  A simulation study of cellular hypertrophy and connexin lateralization in cardiac tissue. , 2010, Biophysical journal.

[44]  M. Chanson,et al.  Transforming growth factor-beta 1 and forskolin modulate gap junctional communication and cellular phenotype of cultured Schwann cells , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  D. Spray,et al.  Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy. , 2010, The Journal of infectious diseases.

[46]  J. Saffitz,et al.  Remodeling of Gap Junctions in Ischemic and Nonischemic Forms of Heart Disease , 2007, Journal of Membrane Biology.

[47]  G. Buck,et al.  Trypanosoma cruzi Infection Induces a Global Host Cell Response in Cardiomyocytes , 2011, Infection and Immunity.

[48]  D. Spray,et al.  Trypanosoma cruzi induces changes in cardiac connexin43 expression. , 2008, Microbes and infection.

[49]  D. Spray,et al.  Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). , 2009, Progress in cardiovascular diseases.

[50]  J. Montgomery,et al.  The synthesis of potential anticancer agents. XXXVI. N-nitrosoureas. II. Haloalkyl derivatives. , 1966, Journal of medicinal chemistry.

[51]  E. L. Olivares,et al.  Sera from chronic chagasic patients depress cardiac electrogenesis and conduction. , 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[52]  K. Cao,et al.  Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. , 2011, International journal of cardiology.

[53]  D. Spray,et al.  Conduction Defects and Arrhythmias in Chagas' Disease: , 1994, Journal of cardiovascular electrophysiology.